GV20 Therapeutics is the US branch of GV20 Oncotherapy. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.

Pharmaceutical

GV20 Therapeutics

GV20 Therapeutics' headquarters in Cambridge, MA, United States

Shirley Liu

Karim Benhadji

Xihao Hu

Sherlock Hu

Ying Gong

Ted Xiao

Alessandra Cesano

Julie Cherrington

Mike Varney

The Leadership Team at GV20 Therapeutics is responsible for driving the strategic vision and operational execution of the company. This team, comprised of co-founders and key executives, oversees the integration of high-throughput functional genomics and AI technologies in drug discovery processes, fosters collaborations and partnerships, and guides the development of innovative immuno-oncology therapies to advance cancer treatment.

Leadership Team

The Research and Development team at GV20 Therapeutics focuses on leveraging high-throughput functional genomics and AI technologies to identify and validate innovative cancer immunology drug targets. This multidisciplinary team collaborates to discover and advance novel antibody drugs, ensuring a robust pipeline of effective therapies for oncology applications. With expertise spanning bioinformatics, research, and scientific leadership, the team drives GV20's mission to revolutionize cancer treatment through cutting-edge drug discovery.

Research and Development

The Information Technology team at GV20 Therapeutics is responsible for implementing and maintaining advanced technological solutions that support the company's innovative research in cancer immunology. This includes managing data systems for high throughput functional genomics, ensuring robust cybersecurity measures, and leveraging AI tools to enhance drug discovery processes. The team's expertise is crucial for streamlining operations, facilitating collaboration, and driving the company's mission to develop effective antibody therapies for cancer treatment.

Information Technology

The Marketing and Communications team at GV20 Therapeutics is responsible for promoting the company’s cutting-edge immuno-oncology advancements and fostering relationships with key stakeholders. This team develops strategic messaging, manages public relations, and oversees digital marketing efforts to effectively communicate GV20's innovative drug discovery capabilities and successes in cancer treatment. Additionally, they work closely with leadership to align marketing strategies with the company's vision and business goals.

GV20 Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Information Technology

Marketing and Communications

Offices

GV20 Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Information Technology

Marketing and Communications

Offices

Related companies